Authors
Latest:
J. Eric Pina-Garza, MD: Increasing the Awareness of EpilepsyThe director of Pediatric Epilepsy at Centennial Children's Hospital spoke about the need to increase epilepsy's awareness and the clinical development of several agents that he is keeping his eyes on.
Latest:
Lilyana Amezcua, MD: Better Understanding MS in the Hispanic CommunityThe associate professor of clinical neurology spoke about the need to understand modifiable social and cultural factors that could impact disease severity and progression.
Latest:
Hannah Cock, MD, MBBS: Challenges in Treating Status EpilepticusThe professor of epilepsy and medical education at St. George’s University Hospital London spoke about the number of challenges plaguing epileptologists when treating patients who present with possible status epilepticus in the hospital.
Latest:
Rare Neurologic Diseases Are Not Truly RareDespite being labeled as rare diseases, a number of neurologic conditions impact more patients than most would believe. The consultant with expertise in ophthalmology, gene therapy, and rare and orphan diseases, chimed in about how these diseases can often be overlooked.
Latest:
Sumeet Vadera, MD: Advances in Epilepsy SurgeryThe director of epilepsy surgery and associate professor of neurosurgery at UC Irvine spoke to the advances that have been made in epilepsy surgery and in noninvasive or minimally invasive techniques, as well as the impact they’ve had on outcomes.
Latest:
Rebecca Stainman, MD: Identifying, Addressing Physician BurnoutThe child neurology resident at NYU Langone spoke about ways for residents to identify and address impaired colleagues that suffer from depression and burnout.
Latest:
Samantha Budd Haeberlien, PhD: Progress in Alzheimer Drug DevelopmentHaeberlein spoke about a number of topics in the Alzheimer space, including the progress that has been made and her excitement for the future.
Latest:
A Holistic Approach to Preserving Brain Health: Costantino Iadecola, MDThe director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine discussed ways to use a comprehensive approach when maintaining brain health. [WATCH TIME: 7 minutes]
Latest:
Samantha Budd Haeberlein, PhD: The TANGO II Trial of BIIB092The vice president and head of Alzheimer’s Disease, Dementia, and Movement Disorders in Late Stage Clinical Development at Biogen spoke about the upcoming TANGO II trial in Alzheimer disease.
Latest:
Revised McDonald Diagnostic Criteria Signals New Era in Multiple Sclerosis TreatmentThe 2024 revisions to the McDonald diagnostic criteria for multiple sclerosis (MS) mark a significant advancement in the early detection and diagnosis of the disease, with new biomarkers and a broadened scope that may lead to earlier intervention and improved patient outcomes.
Latest:
Anthony Fiorino, MD, PhD: Using nVNS in Various Migraine PopulationsThe chief medical officer of electroCore discussed the various data which have been published on the use of noninvasive vagus nerve stimulation in different populations of patients with migraine and headache.
Latest:
Fernando Dangond, MD, MBA: Phase 2 Data on Evobrutinib in MSHead of Global Clinical Development in Neurology at EMD Serono discussed the findings of a phase 2 assessment of the company’s investigational BTK inhibitor evobrutinib in multiple sclerosis.
Latest:
Addressing the Neurologist Shortage Through Career Opportunities and Supporting Early Investigators: Claire Henchcliffe, MD, DPhil, FANA; Ali Ezzati, MDA pair of neurologists from the University of California, Irvine, detailed some of the training and career focuses of large federal agencies in effort to address the shortage of neurologists. [WATCH TIME: 4 minutes]
Latest:
Antiplatelets Versus Anticoagulation For the Treatment of Cervical Artery Dissection: Shadi Yaghi, MDThe associate professor of neurology at Brown University talked about findings from an observational study investigating treatment options antiplatelets and anticoagulation for cervical artery dissection. [WATCH TIME: 8 minutes]
Latest:
Andrew Satlin, MD: Lumateperone for Agitation in Patients with Dementia, Alzheimer DiseaseData from an interim analysis of the lumateperone large phase III clinical trial for agitation in subjects with dementia is expected by the end of 2018.
Latest:
Kelvin Tsoi, PhD: Combination Therapy, Monotherapy in Alzheimer DiseaseAfter identifying and reviewing 76 randomized trials, combination therapy with memantine and AChEIs is confirmed to have no additional benefits over monotherapy.
Latest:
Exploring the Burden of Cerebrovascular Disease in VirginiaLocated in the “Stroke Belt” of the US, Virginia presents a unique perspective on the interplay of social, ethnic, and cultural implications on population health.
Latest:
David Wolk, MD: Utilizing MRI in Alzheimer DiseaseThe co-director of the University of Pennsylvania Memory Center will share additional insights on Alzheimer disease at the upcoming International Congress on the Future of Neurology, taking place September 27-28, 2019 in New York City.
Latest:
The Future Outlook for Alzheimer’s DiseaseSharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.
Latest:
Jenny van der Steen, PhD: Utilizing Palliative Care in DementiaThe associate professor at Leiden University Medical Center detailed how palliative care can be used more effectively in patients with dementia.
Latest:
Clinically Relevant Challenges and Roadblocks of Gene Therapies for Muscular Dystrophies: John Brandsema, MDThe pediatric neurologist at Children’s Hospital of Philadelphia gave perspective on some of the main issues the clinical community is figuring out with gene therapies and their integration to clinical practice. [WATCH TIME: 3 minutes]
Latest:
Refining Our Strategy in Alzheimer Disease: Amyloid, Tau, and BeyondReisa Sperling, MD sat down with NeurologyLive to discuss why she thinks investigational drugs for Alzheimer disease are failing, and what she feels are the most promising treatment avenues.
Latest:
Howard Weiner, MD: Entering a New Era in MSThe director of the Partners Multiple Sclerosis Center at Brigham and Women's Hospital spoke about the future of multiple sclerosis.
